Insider Trading & Ownership of ALISON L. HANNAH

Location: Fort Myers, FL
Summary: The estimated net worth of ALISON L. HANNAH is at least $1,448,309 dollars as of 03 Jun 2025. ALISON L. HANNAH is the Director of NEOGENOMICS INC and owns shares of NEOGENOMICS INC (NEO) stock worth about $1.2M. ALISON L. HANNAH is the Director of RIGEL PHARMACEUTICALS INC and owns shares of RIGEL PHARMACEUTICALS INC (RIGL) stock worth about $202.5K. ALISON L. HANNAH is the Chief Medical Officer of CytomX Therapeutics, Inc. and owns shares of CytomX Therapeutics, Inc. (CTMX) stock worth about $44K.
Signature: /s/ Ali Olivo, Attorney-in-Fact
All Insider Reports: All Insider Reports

Notify me when ALISON L. HANNAH files a new Insider Trading report.

Ownership of ALISON L. HANNAH

Symbol	Company	Relationship	Holdings Value	Report Period
NEO	NEOGENOMICS INC	Director	$1,201,755	01 Jun 2025
RIGL	RIGEL PHARMACEUTICALS INC	Director	$202,512	23 May 2025
CTMX	CytomX Therapeutics, Inc.	Chief Medical Officer	$44,042	19 Jul 2022

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.